Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT
Lyell Immunopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -331.4M | -334.52M | -342.99M | -203.99M | -210.26M | -228.34M | -234.63M | -190.1M | -209.5M | -181.93M | -183.12M | -258.43M | -237.05M | -263.32M | -250.22M | -205.37M | -192.21M | -230.28M |
Depreciation & Amortization | 16.28M | 18.05M | 19.63M | 19.66M | 20.09M | 20.25M | 20.25M | 20.23M | 19.75M | 18.86M | 18.02M | 17.54M | 17.01M | 15.85M | 13.62M | 10.51M | 7.52M | 5.48M |
Stock-Based Compensation | 26.73M | 30.01M | 33.14M | 33.52M | 36.42M | 42.36M | 47.08M | 56.98M | 65.59M | 73.78M | 81.92M | 84.74M | 78.66M | 71.5M | 62.2M | 53.99M | 50.7M | 42.72M |
Other Working Capital | -4.22M | -4.66M | 114K | -659K | 1.57M | 5.21M | 1.96M | -42.21M | -44.32M | -83.26M | -82.21M | -35.82M | -30.82M | 4.01M | 3.92M | 2.18M | -3.88M | -4M |
Other Non-Cash Items | 125.39M | 139.38M | 168.86M | 52.52M | 53.08M | 39.58M | 18.7M | -102.28M | -91.39M | -88.82M | -98.51M | -8.94M | -17.21M | -10.4M | 4.62M | 20.8M | 24.08M | 19.96M |
Deferred Income Tax | n/a | n/a | n/a | -18.15M | -19.8M | -18.52M | -18.52M | 93.53M | 95.17M | 93.9M | 93.9M | 37.38M | 38.47M | 39.46M | 39.51M | -2.25M | -3.13M | -4.19M |
Change in Working Capital | -8.48M | -9.44M | -3.12M | -1.43M | -43K | 4.5M | 3.42M | -41.69M | -42.37M | -83.94M | -82.02M | -35M | -31.01M | 6.4M | 4.01M | 2.51M | -2.86M | -4.57M |
Operating Cash Flow | -171.48M | -175.12M | -162.39M | -155.79M | -158.43M | -159.5M | -163.69M | -163.33M | -162.74M | -167.91M | -169.56M | -162.46M | -150.89M | -140.5M | -126.25M | -119.81M | -115.9M | -170.88M |
Capital Expenditures | -517K | -680K | -464K | -445K | -581K | -1.18M | -2.69M | -7.24M | -9.84M | -16.08M | -24.28M | -29.96M | -38.77M | -56.05M | -65.5M | -80.12M | -81.16M | -63.79M |
Cash Acquisitions | -31.35M | -31.35M | -31.35M | 100.67M | 178.94M | 212.2M | 178.51M | 77.85M | 160.36M | 127.11M | 256.99M | 256.95M | 96.16M | 96.2M | n/a | 40K | 40K | n/a |
Purchase of Investments | -335.34M | -371.11M | -394.71M | -612.69M | -559.54M | -476.33M | -476.88M | -440.56M | -523.07M | -579.47M | -567.11M | -1.02B | -1.13B | -1.26B | -1.21B | -546.54M | -271.23M | -55.29M |
Sales Maturities Of Investments | 504.74M | 573.03M | 548.94M | 581.36M | 626.1M | 651.4M | 663.61M | 618.39M | 546.74M | 481.49M | 419.05M | 378.48M | 414.02M | 493.05M | 617.4M | 752.76M | 783.82M | 760.65M |
Other Investing Acitivies | n/a | 45.34M | 67.36M | -33.3M | -111.58M | -190.18M | -178.51M | 82.94M | 432K | 65.88M | -64.01M | 314.7M | 200.18M | -47.91M | n/a | -680.92M | -656.01M | -710.62M |
Investing Cash Flow | 137.54M | 169.9M | 122.42M | -31.77M | 65.98M | 173.89M | 184.05M | 331.39M | 174.63M | 46.74M | -11.54M | -132.09M | -219.88M | -284.37M | -121.57M | -15.28M | 39.65M | -20.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 35.28M | 36.09M | 36.01M | -123K | 396K | -464K | -457K | -428K | -580K | -530K | -461K | -367K | -531K | -531K | -531K | -531K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 184K | 863K | 889K | 1.65M | 1.5M | 1.84M | 1.74M | 1.85M | 6.75M | 8.01M | 10.63M | 17.17M | 12.94M | 11.11M | 9.44M | 2.38M | 1.89M | 1.26M |
Financial Cash Flow | 621K | 1.3M | 1.33M | 1.65M | 1.5M | 1.84M | 1.74M | 1.85M | 6.75M | 8.01M | 10.63M | 17.17M | 11.88M | 402.92M | 401.24M | 394.18M | 394.75M | 1.25M |
Net Cash Flow | -33.32M | -3.92M | -38.65M | -185.91M | -90.95M | 16.23M | 22.1M | 169.91M | 18.64M | -113.17M | -170.46M | -277.38M | -358.89M | -21.96M | 153.42M | 259.09M | 318.49M | -190.38M |
Free Cash Flow | -172M | -175.8M | -162.86M | -156.23M | -159.01M | -160.68M | -166.38M | -170.57M | -172.58M | -183.99M | -193.83M | -192.42M | -189.66M | -196.55M | -191.75M | -199.93M | -197.06M | -234.67M |